Companies in #Becker muscular dystrophy (BMD)
Found 1 company operating in this sector.
Edgewise Therapeutics is a clinical-stage biopharmaceutical company (NASDAQ: EWTX) developing therapeutics for severe rare neuromuscular and cardiac disorders, with a focus on muscle biology and small molecule engineering.